Labetalol Hydrochloride Injection, USP, 100 mg/ 20 mL (5 mg/mL), 20 mL Multidose Vial, Rx only, labeled as a) Hospira, Inc., Lake Forest, IL 60045, NDC 0409-2267-20; and b) NOVAPLUS, Manufactured by Hospira, Inc., Lake Forest, IL 60045, NDC 0409-2267-25.
Published March 14, 2018 · Recall initiated: February 20, 2018
Summary
FDA records drug Class II recall D-0576-2018, published March 14, 2018 and initiated February 20, 2018. Recalling firm: Hospira Inc. A Pfizer Company; Status: Terminated; Reported quantity: a) 137,975 vials; b) 40,143 vials; Lot: Lots: a) 74370DD, Exp 1FEB2019; 75035DD, 75115DD, Exp 1MAR2019; b) 74230DD, Exp 1FEB2019. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Defective Container: Cracked glass at the rim surface of glass vials, covered by the stopper and crimp seal.
What to do
Voluntary: Firm initiated · Letter
Get an email if LABETALOL HYDROCHLORIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- LABETALOL HYDROCHLORIDE
- Manufacturer
- Hospira Inc. A Pfizer Company
- Distributor
- Nationwide in the USA and Puerto Rico.
- Lot
- Lots: a) 74370DD, Exp 1FEB2019; 75035DD, 75115DD, Exp 1MAR2019; b) 74230DD, Exp 1FEB2019
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDALabetalol Hydrochloride Injection, USP, 20 mg/4 mL (5 mg/mL), 4 mL Single-dose Carpuject, Sterile CartridgeJuly 3, 2024
- FDAAtropine Sulfate Ophthalmic 1% Solution, USP, 5mL per bottle, Sterile, Rx Only, Manufactured by: Akorn, Inc.,March 14, 2018
- FDAVancomycin 1g added to 250mL of 0.9% Sodium Chloride IV bag, Rx only, APOLLOcare, 3801 Mojave Ct., Suite 101,March 14, 2018
- FDADELTA XTEND" Reverse Shoulder System Modular Centered and Eccentric Epiphysis Implants intended for use inMarch 7, 2018
- FDAMallinckrodt Institute Percutaneous Gastrostomy Set Product Usage: Intended for the percutaneous placement ofMarch 7, 2018
- FDALabetalol Hydrochloride Injection, USP, 100 mg/20 mL (5 mg/mL), 20 mL Multidose Vial, packaged 50/20 mL glassJuly 16, 2014
Questions about this recall
Was Labetalol Hydrochloride Injection, USP, 100 mg/ 20 mL (5 mg/mL), 20 mL Multidose Vial, Rx only, labeled as a) Hospira, Inc., Lake Forest, IL 60045, NDC 0409-2267-20; and b) NOVAPLUS, Manufactured by Hospira, Inc., Lake Forest, IL 60045, NDC 0409-2267-25. recalled?
Yes. FDA published recall D-0576-2018 on March 14, 2018. Reported hazard: Defective Container: Cracked glass at the rim surface of glass vials, covered by the stopper and crimp seal.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: LABETALOL HYDROCHLORIDE.